Quietmind Foundation

  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog

Leading Edge Commentary

WHO Rejects Methylfenidate for ADHD

11/8/2020

1 Comment

 
Methylphenidate for ADHD rejected from the WHO Essential Medicines List due to uncertainties in benefit-harm profile
  1. Ole Jakob Storebø1,2, 
  2. Christian Gluud3
I felt a familiar sense of relief when I saw this repudiation of Ritalin and other medications as an effective treatment for attention related disorders. My training as a psychotherapist included the fundamental premise that medication was something to be used as a way to help to work effectiveliy in therapy. This perspective has been eclipsed by the promotion of medication as curative or the only thing that was needed for the remediation of neuropsychiatric disorders. I've spent the last 15 years working with children and adults having been given this diagnosic label and regularly finding that the side effects of these medications were signfiicantly more challenging than was indicated they should expect from their prescribers. I am aware that I'm writing this post the American presidential electtion has been decided in favor oif the candidate who promoted harm reduction with regard to COVID 19 and the climate crisis. The awful truth is that there are alternatives to amphetamines and related medications that have been assiduously avoided being given the funding and clinical attention they deserved. I hope the new administration will seize on this decision by the WHO and fund research to evolve a treatment service delivery system that will enhance cognition and behavior by promoting non-drug, noninvasive neurophysiologically-based methods of self-regulation, e.g., neurofeedback training. 

i think we are witnessing a powerful shift in perspective and hope the new administration in Washington can't act definitively to authorize the Department of Education to focus on recruiting competent, trauma-informed integrative health- oriented professionals to take up the challenge of improving public education. The FDA needs to rebuild its credibility and focus on supporting evidence-based treatment models predicated on doing the less invasive before more invasive interventions. Therapeutic methods that can be delivered remotely are now essential and we have shown that neurofeedback and other neurotherapeutic methods are precisely what's needed to promote improved levels emotional and behavioral regulation and academic perofrmance without risking exposure to COVID 19. 

Quietmind is promoting the use of near infrared light stimulation as a useful part of a broader CV!9 prevention strategy as well as to reduce the severity and likelihood of post-infection neurological symptoms. 

ebm.bmj.com/content/early/2020/04/24/bmjebm-2019-111328
1 Comment
Walter H. Christopher link
8/12/2022 05:47:20 am

What a wonderful post, you have put quite a lot of effort into this one, I can tell. Love everything about this, great post. Hope to see more such posts from you soon.

Reply

Your comment will be posted after it is approved.


Leave a Reply.

    QMF News

    Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general. 

    Archives

    March 2023
    February 2023
    January 2023
    December 2022
    November 2022
    October 2022
    August 2022
    July 2022
    June 2022
    April 2022
    March 2022
    February 2022
    January 2022
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    October 2019
    September 2019
    August 2019
    June 2019
    May 2019
    April 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    April 2018
    March 2018
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017

    Categories

    All
    Alzheimer's
    Biofeedback
    Breathing Training
    Dementia
    Dementia Treatment
    Drug Free Anxiety Treatment
    Infrared Light
    Light Therapy
    Neurofeedback
    Neurotherapy
    Panic Disorder
    Photobiomodulation
    Relaxation
    TBI Treatment
    Therapy

    RSS Feed

Powered by Create your own unique website with customizable templates.
  • Home
  • Services
    • Photobiomodulation (Light Therapy)
    • Neurofeedback
  • About
  • Clinical Trials
    • Light Therapy for Dementia
    • Vielight Clinical Trial
  • Research
  • Equipment
  • Blog